What is the recommended dosing for olanzapine (atypical antipsychotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Olanzapine Dosing

For most patients starting olanzapine, begin with 5-10 mg orally once daily, with a target dose of 10 mg/day within several days. 1

Standard Oral Dosing for Schizophrenia

  • Initial dose: 5-10 mg once daily without regard to meals 1
  • Target dose: 10 mg/day should be reached within several days 1
  • Dose range: 10-15 mg/day was demonstrated effective in clinical trials, though doses above 10 mg/day showed no additional efficacy benefit 1
  • Maximum dose: 20 mg/day - olanzapine is not indicated for doses above this level 1
  • Dose adjustments: If needed, make changes in 5 mg increments at intervals of at least 1 week (time to steady state) 1

Bipolar I Disorder (Manic or Mixed Episodes)

  • Initial dose: 10-15 mg once daily for acute mania 1
  • Dose range: 5-20 mg/day demonstrated antimanic efficacy in 3-4 week trials 1
  • Dose adjustments: Make changes in 5 mg increments at intervals of at least 24 hours 1

Special Populations Requiring Lower Starting Doses

Start with 5 mg once daily in patients who are: 1

  • Debilitated
  • Predisposed to hypotensive reactions
  • Elderly (≥65 years, particularly nonsmoking females)
  • More pharmacodynamically sensitive to olanzapine

Start with 2.5 mg in patients with: 2

  • Hepatic impairment
  • Alzheimer's disease-related agitation

Adolescent Dosing (Schizophrenia)

  • Initial dose: 2.5-5 mg once daily 1
  • Target dose: 10 mg/day 1
  • Dose range: 2.5-20 mg/day (mean modal dose 12.5 mg/day in trials) 1
  • Dose adjustments: Make changes in 2.5-5 mg increments 1
  • Pharmacokinetic data suggest adolescents metabolize olanzapine similarly to nonsmoking adults, making standard adult dosing appropriate for most adolescents 3

Intramuscular Dosing for Acute Agitation

  • Recommended dose: 10 mg IM for agitation associated with schizophrenia or bipolar mania 1
  • Alternative doses: 5 mg or 7.5 mg IM may be considered when clinical factors warrant 1
  • Lower dose populations: 5 mg IM for geriatric patients; 2.5 mg IM for debilitated or hypotension-prone patients 1
  • Repeat dosing: Additional doses up to 10 mg may be given, but wait at least 2 hours after initial dose and 4 hours after second dose 1
  • Maximum daily dose: 30 mg IM total - higher doses or more frequent administration not evaluated 1
  • Clinical trials demonstrated efficacy with IM doses ranging from 2.5-10 mg 4, 2

Important Clinical Considerations

Transition to oral therapy: Once clinically appropriate, switch from IM to oral olanzapine 5-20 mg/day 1

Common pitfalls to avoid:

  • Do not combine IM olanzapine with benzodiazepines in the same syringe - this causes precipitation or delayed reconstitution 1
  • Use extreme caution when combining olanzapine with benzodiazepines due to risk of oversedation, respiratory depression, and reported fatalities 2
  • Assess for orthostatic hypotension before administering subsequent IM doses, especially after maximal dosing (3 doses of 10 mg) 1

Monitoring requirements:

  • Monitor for drowsiness and sedation 2
  • Monitor for orthostatic hypotension, particularly with IM administration 2, 1
  • Monitor metabolic effects (weight gain, glucose, lipids) with long-term use 2

Doses Above 20 mg/day

While the FDA-approved maximum is 20 mg/day, some treatment-resistant patients in clinical practice receive higher doses (up to 40-60 mg/day) 5, 6. However, this exceeds FDA labeling and should only be considered in highly selected treatment-resistant cases, as a large trial showed increased risk of weight gain and elevated prolactin at 40 mg/day compared to 20 mg/day 5.

References

Guideline

Olanzapine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.